Skip to main content
Caplight Logo









Amplio Pharma BV

Amplio Pharma BV

Private
AmsterdamHealthcare & Life Scienceshttps://www.amplio-pharma.com/

Last Round

Seed

Feb 17, 2026

Est. Valuation

$9.5M

Total Funding Raised

$1.4M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Amplio Pharma BV is a pharmaceutical company developing improved versions of existing drugs intended to treat autoimmune diseases like rheumatoid arthritis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

drug reformulationsupergenericspharmacokinetics enhancerPK enhancermethotrexate enhancementautoimmune diseasesrheumatoid arthritisclinical-stage pharmadrug enhancementdrug developmentimmune-mediated inflammatory diseasesIMIDsdrug candidate

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Amplio Pharma BV Comparables

Compare Amplio Pharma BV with similar companies based on industry and business-model similarity.

Amplio Pharma BV comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MAA Laboratories
73%
Elevara Medicines
72%
Halozyme Therapeutics
67%

Amplio Pharma BV Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 17, 2026

Key People

Founding team and executive leadership

Karin von Wachenfeldt

Interim CEO

Executive Team

Marguérite Mensonides Harsema

CEO and Co-founder of BV, Head of Business Development, COO and Co-founder of AB

Founding Team

Amplio Pharma BV Investors

Notable investors and investment history

Amplio Pharma BV investors
InvestorRounds
ROM InWestSeed
Innovatiefonds Noord-HollandSeed
Libertatis Ergo HoldingSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors grew 105% MoM.

  • Feb 17, 2026

    $1.4M round led by Libertatis Ergo Holding.

Amplio Pharma BV Filings

Explore SEC and related filing metadata, where available.

Amplio Pharma BV filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Amplio Pharma BV's valuation, stock price, and market status.

Is Amplio Pharma BV a public or private company?

Amplio Pharma BV is a private company.

What is the current stock price of Amplio Pharma BV?

Amplio Pharma BV is a private company with no public stock price. No recent secondary market data is available.

How much is Amplio Pharma BV worth (valuation)?

Valuation information for Amplio Pharma BV is not publicly available.

Can I buy Amplio Pharma BV stock?

Amplio Pharma BV shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Amplio Pharma BV's last funding round?

Funding round information for Amplio Pharma BV is not publicly available.

Who are the main investors in Amplio Pharma BV?

Investor information for Amplio Pharma BV is not publicly disclosed.

Will Amplio Pharma BV IPO soon?

No public IPO plans have been announced for Amplio Pharma BV.

How can I track Amplio Pharma BV secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Amplio Pharma BV's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAmsterdam
Employee Range8
Year Founded2023
Last FundingFeb 17, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?